Aziz Sawaf
Vermögen: 6 Mio $ am 30.06.2026
Vermögen: 6 Mio $ am 30.06.2026
Aziz Sawaf is currently Director at California Life Sciences Association and Chief Financial Officer & SVP-Operations Strategy at Theravance Biopharma, Inc. Education history includes graduate studies at The Johns Hopkins University, undergraduate studies at the University of Arizona, and an MBA from USC Marshall School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.05.2026 | 344’953 ( 0.67% ) | 6 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Finanzdirektor/CFO | 01.01.2023 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen